(Q40934291)

25 September 2017

1 reference

title

The plasminogen activation system in tumour invasion and metastasis (English)

1 reference

25 September 2017

1 reference

de Vries TJ

1

1 reference

25 September 2017

van Muijen GN

series ordinal

2

1 reference

25 September 2017

Ruiter DJ

series ordinal

3

1 reference

25 September 2017

language of work or name

1 reference

1 July 1996

1 reference

Pathology, Research and Practice

25 September 2017

published in

1 reference

25 September 2017

volume

192

1 reference

25 September 2017

issue

7

1 reference

25 September 2017

page(s)

718-733

1 reference

Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Confocal fluorescence microscopy of urokinase plasminogen activator receptor and cathepsin D in human MDA-MB-231 breast cancer cells migrating in reconstituted basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The plasmin system in human colonic tumors: an immunofluorescence study

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Physiological consequences of loss of plasminogen activator gene function in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Differences in tetranectin immunoreactivity between benign and malignant breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

A tetranectin-related protein is produced and deposited in extracellular matrix by human embryonal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

PMA-induced down-regulation of the receptor for alpha 2-macroglobulin in human U937 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Prevention of metastasis by inhibition of the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Components of the plasminogen activation system in uveal melanoma—a clinico-pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase receptor and colorectal cancer survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

α2‐Macroglobulin and the α2‐Macroglobulin Receptor/LRP A Growth Regulatory Axisa

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

High-affinity urokinase receptor antagonists identified with bacteriophage peptide display

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Immunohistochemical Study of Tumor Cell-associated Plasminogen Activators and Plasminogen Activator Inhibitors in Lung Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activator in mouse and rat oocytes: induction during meiotic maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasma tetranectin is reduced in cancer and related to metastasia

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Regulation of urokinase plasminogen activator localization in keratinocytes by calcium ion and E-cadherin

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activator inhibitors--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Tissue plasminogen activator and inhibitors of fibrinolysis in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Tumor-associated alpha-2-macroglobulin in human melanomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Biology and biochemistry of proteinases in tumor invasion.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase plasminogen activator is immunocytochemically detectable in squamous cell but not basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Surface expression of the alpha 2-macroglobulin receptor on human malignant blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Decreased tetranectin in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Tetranectin: a novel secretory protein from human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Antibodies to plasminogen activator inhibit human tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

A basement-membrane permeability assay which correlates with the metastatic potential of tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activator inhibitor-1 is induced in migrating endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Upregulation of urokinase receptor expression on migrating endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The plasminogen-activation system in ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Influence of fibroblasts on the invasion and migration of highly or weakly metastatic B16 melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Laminin interacts with plasminogen and its tissue-type activator

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Differential protease expression by cutaneous squamous and basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Extracellular proteolysis in the adult murine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Binding of human plasminogen to basement-membrane (type IV) collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Autocrine saturation of pro-urokinase receptors on human A431 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activator system in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Regional variations of urokinase-type plasminogen activator in human colorectal cancer: a quantitative study by image analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Plasminogen activator inhibitor 1 in human carcinoma tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Structure of the gene (LRP1) coding for the human alpha 2-macroglobulin receptor lipoprotein receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Tetranectin expression in human colonic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Transcriptional activation of the urokinase receptor gene in invasive colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Sites within the 39-kDa protein important for regulating ligand binding to the low-density lipoprotein receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Chromosomal localization of the human urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 genes: implications in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Breast cancer prognosis is poor when total plasminogen activator activity is low

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

Comparative localization of receptors for plasmin and for urokinase on MCF 7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2896%2980094-X

7 January 2021

10.1016/S0344-0338(96)80094-X

Identifiers

DOI

0 references

1 reference